文献类型：期刊文献

英文题名：Evaluation of reporting quality of randomized controlled trials in patients with COVID-19 using the CONSORT statement

作者：Yin, Yuhuan[1];Shi, Fugui[2];Zhang, Yiyin[1];Zhang, Xiaoli[1];Ye, Jianying[1];Zhang, Juxia[3]

第一作者：Yin, Yuhuan

通信作者：Zhang, JX[1]

机构：[1]Gansu Univ Chinese Med, Sch Nursing, Lanzhou, Peoples R China;[2]Lanzhou Hand & Foot Surg Hosp, Lanzhou, Gansu, Peoples R China;[3]Gansu Prov Hosp, Clin Educ Dept, Lanzhou, Gansu, Peoples R China

第一机构：甘肃中医药大学护理学院

通信机构：[1]corresponding author), Gansu Prov Hosp, Clin Educ Dept, Lanzhou, Gansu, Peoples R China.

年份：2021

卷号：16

期号：9

外文期刊名：PLOS ONE

收录：;Scopus(收录号：2-s2.0-85115768439);WOS:【SCI-EXPANDED(收录号:WOS:000725694500018)】；

基金：The study was funded by Horizontal project of School of Public Health of Lanzhou University "Research on the Thinking, difficulties and Countermeasures of High-quality Development of Lanzhou Hand and Foot Surgery Hospital" (071100278), Gansu Science and Technology Plan (Innovation Base and Talent Plan) project (21JR7RA607), and Health industry scientific research project of Gansu Province (GSWSKY-2019-50), received by Fugui Shi and Juxia Zhang.

语种：英文

摘要：Objective To evaluate the reporting quality of randomized controlled trials (RCTs) regarding patients with COVID-19 and analyse the influence factors. Methods PubMed, Embase, Web of Science and the Cochrane Library databases were searched to collect RCTs regarding patients with COVID-19. The retrieval time was from the inception to December 1, 2020. The CONSORT 2010 statement was used to evaluate the overall reporting quality of these RCTs. Results 53 RCTs were included. The study showed that the average reporting rate for 37 items in CONSORT checklist was 53.85% with mean overall adherence score of 13.023.546 (ranged: 7 to 22). The multivariate linear regression analysis showed the overall adherence score to the CONSORT guideline was associated with journal impact factor (P = 0.006), and endorsement of CONSORT statement (P = 0.014). Conclusion Although many RCTs of COVID-19 have been published in different journals, the overall reporting quality of these articles was suboptimal, it can not provide valid evidence for clinical decision-making and systematic reviews. Therefore, more journals should endorse the CONSORT statement, authors should strictly follow the relevant provisions of the CONSORT guideline when reporting articles. Future RCTs should particularly focus on improvement of detailed reporting in allocation concealment, blinding and estimation of sample size.